Mechanisms of Mg 2+ inhibition of BzATP-dependent Ca 2+ responses in THP-1 monocytes

Brain Research

Volumn 1442, Issue , 2012, Pages 1-8

  Jantaratnotai, Nattinee ^a,b   McGeer, Patrick L ^a   McLarnon, James G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Mg 2+; P2X 7 receptor; Purinergic signaling; Store operated Ca 2+ channel

Indexed keywords

2',3' [BENZOYL 4 BENZOYL] ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIUM ION; GAMMA INTERFERON; INTRACELLULAR CALCIUM SENSING PROTEIN; IONOTROPIC RECEPTOR; MAGNESIUM ION; UNCLASSIFIED DRUG; 1 (2 (3 (4 METHOXYPHENYL)PROPOXY) 4 METHOXYPHENYLETHYL) 1H IMIDAZOLE; 1-(2-(3-(4-METHOXYPHENYL)PROPOXY)-4-METHOXYPHENYLETHYL)-1H-IMIDAZOLE; 2',3' DIALDEHYDE ATP; 2',3'-DIALDEHYDE ATP; 3' O (4 BENZOYL)BENZOYLADENOSINE 5' TRIPHOSPHATE; 3'-O-(4-BENZOYL)BENZOYLADENOSINE 5'-TRIPHOSPHATE; CALCIUM; DRUG DERIVATIVE; IMIDAZOLE DERIVATIVE; LIPOPOLYSACCHARIDE; MAGNESIUM; PURINERGIC P2X RECEPTOR AGONIST; PURINERGIC P2X RECEPTOR ANTAGONIST; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y RECEPTOR;

ARTICLE; CALCIUM INTAKE; CONTROLLED STUDY; ENCEPHALITIS; HUMAN; HUMAN CELL; MONOCYTE; NEUROPROTECTION; PRIORITY JOURNAL; BIOLOGICAL MODEL; IMMUNOLOGY; METABOLISM; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATE; CALCIUM; CELL LINE, TUMOR; HUMANS; IMIDAZOLES; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; MAGNESIUM; MODELS, BIOLOGICAL; MONOCYTES; PURINERGIC P2X RECEPTOR AGONISTS; PURINERGIC P2X RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2X7; RECEPTORS, PURINERGIC P2Y;

EID: 84857365843     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.01.004     Document Type: Article

References (35)

1. L.M. Carrasquero, E.G. Delicado, D. Bustillo, Y. Gutierrez-Martin, A.R. Artalejo, and M.T. Miras-Portugal P2X7 and P2Y13 purinergic receptors mediate intracellular calcium responses to BzATP in rat cerebellar astrocytes J. Neurochem. 110 2009 879 889
2. L. Chen, and C.F. Brosnan Regulation of immune response by P2X7 receptor Crit. Rev. Immunol. 26 2006 499 513
3. I.P. Chessell, A.D. Michel, and P.P. Humphrey Effects of antagonists at the human recombinant P2X7 receptor Br. J. Pharmacol. 124 1998 1314 1320 (Pubitemid 28333958)
4. H.B. Choi, S.H. Hong, J.K. Ryu, S.U. Kim, and J.G. McLarnon Differential activation of subtype purinergic receptors modulates Ca(2+) mobilization and COX-2 in human microglia Glia 43 2003 95 103 (Pubitemid 36897271)
5. H.B. Choi, J.K. Ryu, S.U. Kim, and J.G. McLarnon Modulation of the purinergic P2X7 receptor attenuates lipopolysaccharide-mediated microglial activation and neuronal damage in inflamed brain J. Neurosci. 27 2007 4957 4968 (Pubitemid 46699068)
6. E.E. Clifford, K.A. Martin, P. Dalal, R. Thomas, and G.R. Dubyak Stage-specific expression of P2Y receptors, ecto-apyrase, and ecto-5′-nucleotidase in myeloid leukocytes Am. J. Physiol. 273 1997 C973 C987
7. F. Di Virgilio Novel data point to a broader mechanism of action of oxidized ATP: the P2X7 receptor is not the only target Br. J. Pharmacol. 140 2003 441 443 (Pubitemid 37330488)
8. F. Di Virgilio, S. Ceruti, P. Bramanti, and M.P. Abbracchio Purinergic signalling in inflammation of the central nervous system Trends Neurosci. 32 2009 79 87
9. S. Duan, and J.T. Neary P2X(7) receptors: properties and relevance to CNS function Glia 54 2006 738 746 (Pubitemid 44629636)
10. G.R. Dubyak, and C. el-Moatassim Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides Am. J. Physiol. 265 1993 C577 606
11. D. Ferrari, C. Pizzirani, E. Adinolfi, R.M. Lemoli, A. Curti, M. Idzko, E. Panther, and F. Di Virgilio The P2X7 receptor: a key player in IL-1 processing and release J. Immunol. 176 2006 3877 3883 (Pubitemid 44264361)
12. H. Franke, A. Gunther, J. Grosche, R. Schmidt, S. Rossner, R. Reinhardt, H. Faber-Zuschratter, D. Schneider, and P. Illes P2X7 receptor expression after ischemia in the cerebral cortex of rats J. Neuropathol. Exp. Neurol. 63 2004 686 699 (Pubitemid 38891085)
13. 2+ signalling in glial cell pathology in the central nervous system Eur. J. Pharmacol. 447 2002 247 260 (Pubitemid 34874458)
14. N. Jantaratnotai, H.B. Choi, and J.G. McLarnon ATP stimulates chemokine production via a store-operated calcium entry pathway in C6 glioma cells BMC Cancer 9 2009 442
15. A. Klegeris, H.B. Choi, J.G. McLarnon, and P.L. McGeer Functional ryanodine receptors are expressed by human microglia and THP-1 cells: their possible involvement in modulation of neurotoxicity J. Neurosci. Res. 85 2007 2207 2215 (Pubitemid 47172152)
16. V.L. Kolachala, R. Bajaj, M. Chalasani, and S.V. Sitaraman Purinergic receptors in gastrointestinal inflammation Am. J. Physiol. Gastrointest. Liver Physiol. 294 2008 G401 G410
17. H.G. Lee, S.M. Won, B.J. Gwag, and Y.B. Lee Microglial P2X receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe/PS1dE9 mouse model of Alzheimer's disease Exp. Mol. Med. 43 2011 7 14
18. 2+ entry through purinergic channels Brain Res. 1369 2011 21 35
19. M. Lin, M.X. Zhu, and Y. Rikihisa Rapid activation of protein tyrosine kinase and phospholipase C-gamma2 and increase in cytosolic free calcium are required by Ehrlichia chaffeensis for internalization and growth in THP-1 cells Infect. Immun. 70 2002 889 898 (Pubitemid 34086923)
20. 2+ mobilization and functional responses in microglia: effects of low levels of ATP J. Neurosci. Res. 81 2005 349 356 (Pubitemid 41359289)
21. J.G. McLarnon, H.B. Choi, L.F. Lue, D.G. Walker, and S.U. Kim Perturbations in calcium-mediated signal transduction in microglia from Alzheimer's disease patients J. Neurosci. Res. 81 2005 426 435 (Pubitemid 41359297)
22. J.G. McLarnon, J.K. Ryu, D.G. Walker, and H.B. Choi Upregulated expression of purinergic P2X(7) receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide-injected rat hippocampus J. Neuropathol. Exp. Neurol. 65 2006 1090 1097 (Pubitemid 44684667)
23. J.E. Merritt, W.P. Armstrong, C.D. Benham, T.J. Hallam, R. Jacob, A. Jaxa-Chamiec, B.K. Leigh, S.A. McCarthy, K.E. Moores, and T.J. Rink SK&F 96365, a novel inhibitor of receptor-mediated calcium entry Biochem. J. 271 1990 515 522 (Pubitemid 20344770)
24. M. Monif, C.A. Reid, K.L. Powell, M.L. Smart, and D.A. Williams The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore J. Neurosci. 29 2009 3781 3791
25. D.J. Moore, J.K. Chambers, J.P. Wahlin, K.B. Tan, G.B. Moore, O. Jenkins, P.C. Emson, and P.R. Murdock Expression pattern of human P2Y receptor subtypes: a quantitative reverse transcription-polymerase chain reaction study Biochim. Biophys. Acta 1521 2001 107 119 (Pubitemid 33020772)
26. M. Murgia, S. Hanau, P. Pizzo, M. Rippa, and F. Di Virgilio Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor J. Biol. Chem. 268 1993 8199 8203 (Pubitemid 23120407)
27. R.A. North Molecular physiology of P2X receptors Physiol. Rev. 82 2002 1013 1067
28. L.K. Parvathenani, S. Tertyshnikova, C.R. Greco, S.B. Roberts, B. Robertson, and R. Posmantur P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease J. Biol. Chem. 278 2003 13309 13317 (Pubitemid 36800102)
29. D. Rampe, L. Wang, and G.E. Ringheim P2X7 receptor modulation of beta-amyloid- and LPS-induced cytokine secretion from human macrophages and microglia J. Neuroimmunol. 147 2004 56 61 (Pubitemid 38114947)
30. A. Singh, M.E. Hildebrand, E. Garcia, and T.P. Snutch The transient receptor potential channel antagonist SKF96365 is a potent blocker of low-voltage-activated T-type calcium channels Br. J. Pharmacol. 160 2010 1464 1475
31. S.D. Skaper, P. Debetto, and P. Giusti The P2X7 purinergic receptor: from physiology to neurological disorders FASEB J. 24 2010 337 345
32. D. Suplat-Wypych, A. Dygas, and J. Baranska 2′, 3′-O-(4-benzoylbenzoyl)-ATP-mediated calcium signaling in rat glioma C6 cells: role of the P2Y(2) nucleotide receptor Purinergic Signal. 6 2010 317 325
33. 2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells J. Neurochem. 102 2007 1518 1532 (Pubitemid 47256191)
34. I. von Kugelgen Pharmacological profiles of cloned mammalian P2Y-receptor subtypes Pharmacol. Ther. 110 2006 415 432
35. 2+ influx in human microglia Cell Calcium 27 2000 205 212 (Pubitemid 30312460)